Compounds > naphthyridinomycin
Page last updated: 2024-12-10

naphthyridinomycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

naphthyridinomycin: antibiotic isolated from culture filtrate of Streptomyces lusitanus; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID102148112
MeSH IDM0056503

Synonyms (1)

Synonym
naphthyridinomycin
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (26.67)18.7374
1990's4 (26.67)18.2507
2000's2 (13.33)29.6817
2010's4 (26.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
oxazoles
Oxazoles: Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions.. 1,3-oxazole : A five-membered monocyclic heteroarene that is an analogue of cyclopentadiene with O in place of CH2 at position 1 and N in place of CH at position 3.. oxazole : An azole based on a five-membered heterocyclic aromatic skeleton containing one N and one O atom.		3.55201,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
cyanonaphthyridinomycin
cyanonaphthyridinomycin: derivative of naphthyridinomycin		9.0140
saframycin a
saframycin A: structure given in first source		2.4620
ecteinascidin 743
[no description available]		210acetate ester;
azaspiro compound;
bridged compound;
hemiaminal;
isoquinoline alkaloid;
lactone;
organic heteropolycyclic compound;
organic sulfide;
oxaspiro compound;
polyphenol;
tertiary amino compound		alkylating agent;
angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
marine metabolite
nadp
[no description available]		2.3110
lemonomycin
lemonomycin: structure in first source		8.1410
oligonucleotides
[no description available]		210
ConditionIndicatedRelationship StrengthStudiesTrials